KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Pension: 2011-2012

Historic Pension for Supernus Pharmaceuticals (SUPN) over the last 1 years, with Dec 2012 value amounting to $279,000.

  • Supernus Pharmaceuticals' Pension rose 13.88% to $279,000 in Q4 2012 from the same period last year, while for Dec 2012 it was $279,000, marking a year-over-year increase of 13.88%. This contributed to the annual value of $279,000 for FY2012, which is 13.88% up from last year.
  • Supernus Pharmaceuticals' Pension amounted to $279,000 in Q4 2012, which was up 1.45% from $275,000 recorded in Q3 2012.
  • Supernus Pharmaceuticals' 5-year Pension high stood at $279,000 for Q4 2012, and its period low was $245,000 during Q4 2011.
  • In the last 2 years, Supernus Pharmaceuticals' Pension had a median value of $275,000 in 2012 and averaged $266,800.
  • Data for Supernus Pharmaceuticals' Pension shows a peak YoY increased of 13.88% (in 2012) over the last 5 years.
  • Supernus Pharmaceuticals' Pension (Quarterly) stood at $245,000 in 2011, then grew by 13.88% to $279,000 in 2012.
  • Its last three reported values are $279,000 in Q4 2012, $275,000 for Q3 2012, and $259,000 during Q2 2012.